Inventor
Steven H. Olson
Inventor
Millbrae, CA, US
Overview
Patents· 22 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07DHeterocyclic compounds25%
A61KPreparations for medical, dental or toiletry purposes18%
C07CAcyclic or carbocyclic compounds11%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium11%
C07BGeneral methods of organic chemistry10%
C07HSugars1%
PatentTitleYear
11,046,680Heteroaryl-substituted triazoles as APJ receptor agonists202110,736,883Triazole furan compounds as agonists of the APJ receptor202010,221,162Triazole agonists of the APJ receptor201910,150,760Compounds for use in preparing heterocyclic triazole agonists of the APJ receptor20189,988,369Heterocyclic triazole compounds as agonists of the APJ receptor20189,868,721'Triazole agonists of the APJ receptor'20189,845,310Intermediates for preparing triazole agonists of the APJ receptor20179,758,495'Heteroaryl acid morpholinone compounds as MDM2 inhibitors for the treatment of cancer'20179,751,864'Methods for preparing triazole agonists of the APJ receptor'20179,745,286'Triazole agonists of the APJ receptor'20179,656,997'Triazole agonists of the APJ receptor'20179,656,998'Intermediates for preparing triazole agonists of the APJ receptor'20179,593,129'Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer'20179,573,936'Triazole agonists of the APJ receptor'20179,376,425'Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer'20169,365,522'Pyrazole amide derivative'20169,296,736'Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer'20167,329,683'11-β-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia'20087,179,802'11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia'20076,916,846'Coumermycin analogs as chemical dimerizers of chimeric proteins'20056,730,690'11--hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia'20046,630,510'Substituted succinic acid metallo--lactamase inhibitors and their use in treating bacterial infections'2003Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2003–2008Patents assigned to MERCK & CO INC (5)· patent assignee history
2003–2007Based in Metuchen, NJ, US· patent location history
2008Based in Clark, NJ, US· patent location history
2016–2021Patents assigned to AMGEN INC (17)· patent assignee history
2016Patents assigned to TEIJIN PHARMA LTD (1)· patent assignee history
2016–2021Based in Millbrae, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AMGEN INC | 17 | 2016–2021 |
| MERCK & CO INC | 5 | 2003–2008 |
| TEIJIN PHARMA LTD | 1 | 2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Millbrae, California, US | 17 | 2016–2021 |
| Metuchen, New Jersey, US | 4 | 2003–2007 |
| Clark, New Jersey, US | 1 | 2008 |